Learning From Our Patients, Learning From Our Practice: Implementing an

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05031013` - Trace Elements Concentration in Dialysis
Not yet recruiting	`NCT03090828` - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease	N/A
Completed	`NCT01685372` - Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults	Phase 2
Active, not recruiting	`NCT01394770` - Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients	Phase 4
Completed	`NCT00537979` - Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis	Phase 4
Completed	`NCT00506441` - A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia	Phase 3
Completed	`NCT05415969` - CKD-aP Among Adults on Dialysis in Switzerland
Recruiting	`NCT04024007` - Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
Completed	`NCT03772171` - Estimate for Dietary Intakes and Hemodialysis Patients
Recruiting	`NCT02586402` - Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis	Phase 2
Active, not recruiting	`NCT01693263` - Outcome of BCF Access in Hemodialysis Patients
Completed	`NCT01421771` - Blood Pressure in Dialysis Patients	N/A
Active, not recruiting	`NCT01065389` - Resistance Training in Intradialysis Patients	Phase 2
Completed	`NCT00544492` - Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients	Phase 4
Completed	`NCT03910426` - Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
Completed	`NCT04667741` - Post-dialysis Recovery Time and Affecting Factors Between Turkey and Portugal
Completed	`NCT04565522` - Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers
Completed	`NCT04655989` - A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System	N/A
Completed	`NCT05125848` - Clinical Evaluation of the CM-1500 During Hemodialysis	N/A
Completed	`NCT04633915` - Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.

NCT number	NCT04924582
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	July 23, 2021
Completion date	June 20, 2023

Learning From Our Patients, Learning From Our Practice: Implementing an Intervention to Support Patients on Dialysis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms